Faculty Profiles - FURUKAWA Taiki

写真a

FURUKAWA Taiki

Organization

Nagoya University Hospital Medical IT Center Lecturer

Graduate School

Graduate School of Medicine

Profile

平成23年3月名古屋大学医学部医学科卒業
平成23年4月公立陶生病院初期研修医
平成26年4月公立陶生病院呼吸器・アレルギー疾患内科専攻医
平成29年4月名古屋大学大学院医学系研究科呼吸器内科学医員
　　　 10月理化学研究所画像情報処理研究チーム
平成30年11月名古屋大学医学部附属病院メディカルITセンター医員
令和3年4月名古屋大学医学部附属病院メディカルITセンター特任助教
令和5年6月名古屋大学医学部附属病院メディカルITセンター講師 (副センター長)

Degree 1

博士（医学）（ 2021.3 名古屋大学）

To the head of Degree.▲

Research Areas 2

Informatics / Life, health and medical informatics / 医療情報学
Life Science / Respiratory medicine

To the head of Research Areas.▲

Current Research Project and SDGs 2

All Japan大規模レジストリデータを背景とした間質性肺炎の治療プログラム及びデバイスの開発
人工衛星による大気汚染情報を活用した間質性肺炎プレシジョンメディシンの実現

To the head of Current Research Project and SDGs.▲

Research History 3

Nagoya University Medical IT Center, Hospital Lecturer

2023.6
RIKEN

2021.4
Nagoya University Medical IT Center, Hospital Designated assistant professor

2021.4 - 2023.5

To the head of Research History.▲

Professional Memberships 5

日本メディカルAI学会

2023.6
Japan Association for Medical Informatics

2021.5
The Japanese Society for Artificial Intelligence

2021.4
Japanese Respiratory Society

2013.10
Japanese Society of Allergology

2012.4

To the head of Professional Memberships.▲

Committee Memberships 3

日本呼吸器学会 MDD保険診療資格等認定委員会

2023.8

　 More details

Committee type：Academic society
厚生労働省難治性疾患等政策研究事業「びまん性肺疾患に関する調査研究」班研究協力者

2023.4

　 More details

Committee type：Other
日本呼吸器学会びまん性肺疾患MDD診断保険収載検討タスクフォース幹事

2021.10

　 More details

Committee type：Academic society

To the head of Committee Memberships.▲

Awards 1

Fukuchi Award

2023.11 Asian Pacific Society of Respirology (APSR) A comprehensible machine learning tool to differentially diagnose idiopathic pulmonary fibrosis from other chronic interstitial lung diseases

Furukawa, T, Oyama, S, Yokota, H, Kondoh, Y, Kataoka, K, Johkoh, T, Fukuoka, J, Hashimoto, N, Sakamoto, K, Shiratori, Y, Hasegawa, Y

To the head of Awards.▲

Papers 20

A comprehensible machine learning tool to differentially diagnose idiopathic pulmonary fibrosis from other chronic interstitial lung diseases. Reviewed International journal

Taiki Furukawa, Shintaro Oyama, Hideo Yokota, Yasuhiro Kondoh, Kensuke Kataoka, Takeshi Johkoh, Junya Fukuoka, Naozumi Hashimoto, Koji Sakamoto, Yoshimune Shiratori, Yoshinori Hasegawa

Respirology (Carlton, Vic.) Vol. 27 ( 9 ) page： 739 - 746 2022.9

　More details

Authorship：Lead author,　Corresponding author Language：English Publishing type：Research paper (scientific journal)

BACKGROUND AND OBJECTIVE: Idiopathic pulmonary fibrosis (IPF) has poor prognosis, and the multidisciplinary diagnostic agreement is low. Moreover, surgical lung biopsies pose comorbidity risks. Therefore, using data from non-invasive tests usually employed to assess interstitial lung diseases (ILDs), we aimed to develop an automated algorithm combining deep learning and machine learning that would be capable of detecting and differentiating IPF from other ILDs. METHODS: We retrospectively analysed consecutive patients presenting with ILD between April 2007 and July 2017. Deep learning was used for semantic image segmentation of HRCT based on the corresponding labelled images. A diagnostic algorithm was then trained using the semantic results and non-invasive findings. Diagnostic accuracy was assessed using five-fold cross-validation. RESULTS: In total, 646,800 HRCT images and the corresponding labelled images were acquired from 1068 patients with ILD, of whom 42.7% had IPF. The average segmentation accuracy was 96.1%. The machine learning algorithm had an average diagnostic accuracy of 83.6%, with high sensitivity, specificity and kappa coefficient values (80.7%, 85.8% and 0.665, respectively). Using Cox hazard analysis, IPF diagnosed using this algorithm was a significant prognostic factor (hazard ratio, 2.593; 95% CI, 2.069-3.250; p < 0.001). Diagnostic accuracy was good even in patients with usual interstitial pneumonia patterns on HRCT and those with surgical lung biopsies. CONCLUSION: Using data from non-invasive examinations, the combined deep learning and machine learning algorithm accurately, easily and quickly diagnosed IPF in a population with various ILDs.

DOI： 10.1111/resp.14310

Web of Science

Scopus

PubMed
Analysis of In-Hospital Morality Prediction by Machine Learning Reviewed

TAIKI FURUKAWA, SHOTARO MISAWA, SHINTARO OYAMA RYUJI KANO, HIROKAZU YARIMIZU, TOMOKI TANIGUCHI, KOHEI ONODA, KIKUE SATO, YOSHIMUNE SHIRATORI

JAPAN JOURNAL OF MEDICAL INFORMATICS Vol. 44 ( 1 ) page： 29 - 37 2024.4

　More details

Authorship：Lead author,　Corresponding author Language：Japanese Publishing type：Research paper (scientific journal)
Mild elevation of pulmonary vascular resistance predicts mortality regardless of mean pulmonary artery pressure in mild interstitial lung disease Reviewed International journal

Tomonori Sato, Taiki Furukawa, Ryo Teramachi, Jun Fukihara, Yasuhiko Yamano, Toshiki Yokoyama, Toshiaki Matsuda, Kensuke Kataoka, Tomoki Kimura, Koji Sakamoto, Makoto Ishii, Yasuhiro Kondoh

Thorax Vol. 79 ( 5 ) page： 422 - 429 2024.2

　More details

Authorship：Lead author Language：English Publishing type：Research paper (scientific journal)

DOI： 10.1136/thorax-2023-220179

Web of Science

Scopus

PubMed
Predictive Models for Palliative Care Needs of Advanced Cancer Patients Receiving Chemotherapy. Reviewed International journal

Arisa Kawashima, Taiki Furukawa, Takahiro Imaizumi, Akemi Morohashi, Mariko Hara, Satomi Yamada, Masayo Hama, Aya Kawaguchi, Kazuki Sato

Journal of pain and symptom management Vol. 67 ( 4 ) page： 306 - 316.e6 2024.1

　More details

Language：English Publishing type：Research paper (scientific journal)

CONTEXT: Early palliative care is recommended within eight-week of diagnosing advanced cancer. Although guidelines suggest routine screening to identify cancer patients who could benefit from palliative care, implementing screening can be challenging due to understaffing and time constraints. OBJECTIVES: To develop and evaluate machine learning models for predicting specialist palliative care needs in advanced cancer patients undergoing chemotherapy, and to investigate if predictive models could substitute screening tools. METHODS: We conducted a retrospective cohort study using supervised machine learning. The study included patients aged 18 or older, diagnosed with metastatic or stage IV cancer, who underwent chemotherapy and distress screening at a designated cancer hospital in Japan from April 1, 2018, to March 31, 2023. Specialist palliative care needs were assessed based on distress screening scores and expert evaluations. Data sources were hospital's cancer registry, health claims database, and nursing admission records. The predictive model was developed using XGBoost, a machine learning algorithm. RESULTS: Out of the 1878 included patients, 561 were analyzed. Among them, 114 (20.3%) exhibited needs for specialist palliative care. After under-sampling to address data imbalance, the models achieved an Area Under the Curve (AUC) of 0.89 with 95.8% sensitivity and a specificity of 71.9%. After feature selection, the model retained five variables, including the patient-reported pain score, and showcased an 0.82 AUC. CONCLUSION: Our models could forecast specialist palliative care needs for advanced cancer patients on chemotherapy. Using five variables as predictors could replace screening tools and has the potential to contribute to earlier palliative care.

DOI： 10.1016/j.jpainsymman.2024.01.009

Scopus

PubMed
Artificial intelligence in a prediction model for post-ERCP pancreatitis Reviewed International journal

Takahashi Hidekazu, Eizaburo Ohno, Taiki Furukawa, Kentaro Yamao, Takuya Ishikawa, Yasuyuki Mizutani, Tadashi Iida, Yoshimune Shiratori, Shintaro Oyama, Junji Koyama, Kensaku Mori, Yuichiro Hayashi, Masahiro Oda, Takahisa Suzuki, Hiroki Kawashima

Digestive Endoscopy Vol. 36 ( 4 ) page： 463 - 472 2023.7

　More details

Language：English Publishing type：Research paper (scientific journal)

OBJECTIVES: In this study we aimed to develop an artificial intelligence-based model for predicting postendoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). METHODS: We retrospectively reviewed ERCP patients at Nagoya University Hospital (NUH) and Toyota Memorial Hospital (TMH). We constructed two prediction models, a random forest (RF), one of the machine-learning algorithms, and a logistic regression (LR) model. First, we selected features of each model from 40 possible features. Then the models were trained and validated using three fold cross-validation in the NUH cohort and tested in the TMH cohort. The area under the receiver operating characteristic curve (AUROC) was used to assess model performance. Finally, using the output parameters of the RF model, we classified the patients into low-, medium-, and high-risk groups. RESULTS: A total of 615 patients at NUH and 544 patients at TMH were enrolled. Ten features were selected for the RF model, including albumin, creatinine, biliary tract cancer, pancreatic cancer, bile duct stone, total procedure time, pancreatic duct injection, pancreatic guidewire-assisted technique without a pancreatic stent, intraductal ultrasonography, and bile duct biopsy. In the three fold cross-validation, the RF model showed better predictive ability than the LR model (AUROC 0.821 vs. 0.660). In the test, the RF model also showed better performance (AUROC 0.770 vs. 0.663, P = 0.002). Based on the RF model, we classified the patients according to the incidence of PEP (2.9%, 10.0%, and 23.9%). CONCLUSION: We developed an RF model. Machine-learning algorithms could be powerful tools to develop accurate prediction models.

DOI： 10.1111/den.14622

Web of Science

Scopus

PubMed
Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis Reviewed International journal

Reoto Takei, Toshiaki Matsuda, Jun Fukihara, Hajime Sasano, Yasuhiko Yamano, Toshiki Yokoyama, Kensuke Kataoka, Tomoki Kimura, Atsushi Suzuki, Taiki Furukawa, Junya Fukuoka, Takeshi Johkoh, Yasuhiro Kondoh

Frontiers in Medicine Vol. 10 page： 1067149 2023.6

　More details

Language：English Publishing type：Research paper (scientific journal) Publisher：Frontiers Media SA

Background

Health-related quality of life (HRQoL) captures different aspects of the fibrotic interstitial lung disease (FILD) evaluation from the patient’s perspective. However, little is known about how HRQoL changes in patients with non-idiopathic pulmonary fibrosis (IPF) FILD, especially in those with progressive pulmonary fibrosis (PPF). The aim of this study is to clarify whether HRQoL deteriorates in patients with non-IPF FILD and to evaluate the differences in the changes in HRQoL between those with and without PPF.

Methods

We collected data from consecutive patients with non-IPF FILD and compared annual changes in HRQoL over 2 years between patients with PPF and those without. The St George’s respiratory questionnaire (SGRQ) and COPD assessment test (CAT) were used to assess HRQoL. Changes in the SGRQ and CAT scores for 24 months from baseline were evaluated with a mixed-effect model for repeated measures.

Results

A total of 396 patients with non-IPF FILD were reviewed. The median age was 65 years and 202 were male (51.0%). The median SGRQ and CAT scores were 29.6 and 11, respectively. Eighty-six (21.7%) showed PPF. Both SGRQ and CAT scores were significantly deteriorated in patients with PPF compared to those without PPF (p &lt; 0.01 for both). Clinically important deterioration in the SGRQ and CAT scores were observed in 40.0 and 35.7% of patients with PPF and 11.7 and 16.7% of those without, respectively. PPF was significantly associated with clinically important deterioration in the SGRQ score (odds ratio 5.04; 95%CI, 2.61–9.76, p &lt; 0.01) and CAT score (odds ratio 2.78; 95%CI, 1.27–6.06, p = 0.02).

Conclusion

The SGRQ and CAT scores were significantly deteriorated in patients with non-IPF FILD and PPF. Considering an evaluation of HRQoL would be needed when assessing PPF.

DOI： 10.3389/fmed.2023.1067149

Web of Science

Scopus

PubMed
DEVELOPMENT OF A MACHINE-LEARNING MODEL FOR PREDICTING POST-ERCP PANCREATITIS Reviewed International journal

Takahashi Hidekazu, Eizaburo Ohno, Taiki Furukawa, Kentaro Yamao, Takuya Ishikawa, Yasuyuki Mizutani, Tadashi Iida, Yoshimune Shiratori, Shintaro Oyama, Junji Koyama, Kensaku Mori, Yuichiro Hayashi, Masahiro Oda, Takahisa Suzuki, Hiroki Kawashima

Gastrointestinal Endoscopy Vol. 97 ( 6 ) page： AB656 - AB656 2023.6

　More details

Language：English Publishing type：Research paper (international conference proceedings) Publisher：Elsevier BV

DOI： 10.1016/j.gie.2023.04.1087
機械学習による院内死亡予測モデルの特性分析 Reviewed

古川大記, 三沢翔太郎, 大山慎太郎, 狩野竜示, 鑓水大和, 谷口友紀, 小野田浩平, 佐藤菊枝, 白鳥義宗

日本医療情報学会春季学術大会プログラム・抄録集 Vol. 27回 page： 74 - 75 2023.6

　More details

Authorship：Lead author Language：Japanese Publishing type：Research paper (other academic) Publisher：(一社)日本医療情報学会
In-Hospital Cancer Mortality Prediction by Multimodal Learning of Non-English Clinical Texts International journal

Oyama S., Furukawa T., Misawa S., Kano R., Yarimizu H., Taniguchi T., Onoda K., Sato K., Shiratori Y.

Studies in Health Technology and Informatics Vol. 302 page： 821 - 822 2023.5

　More details

Language：English Publishing type：Research paper (international conference proceedings) Publisher：Studies in Health Technology and Informatics

Predicting important outcomes in patients with complex medical conditions using multimodal electronic medical records remains challenge. We trained a machine learning model to predict the inpatient prognosis of cancer patients using EMR data with Japanese clinical text records, which has been considered difficult due to its high context. We confirmed high accuracy of the mortality prediction model using clinical text in addition to other clinical data, suggesting applicability of this method to cancer.

DOI： 10.3233/SHTI230276

Scopus

PubMed
Interstitial pneumonia with autoimmune features and histologic usual interstitial pneumonia treated with anti-fibrotic versus immunosuppressive therapy Reviewed International journal

Yasuhiko Yamano, Kensuke Kataoka, Reoto Takei, Hajime Sasano, Toshiki Yokoyama, Toshiaki Matsuda, Tomoki Kimura, Yuta Mori, Taiki Furukawa, Junya Fukuoka, Takeshi Johko, Yasuhiro Kondoh

Respiratory Investigation Vol. 61 ( 3 ) page： 297 - 305 2023.5

　More details

Language：English Publishing type：Research paper (scientific journal)

Background: Therapeutic strategies in patients with interstitial pneumonia with autoimmune features (IPAF) and histological usual interstitial pneumonia (UIP) pattern (IPAF-UIP) have not been thoroughly evaluated. We compared the therapeutic efficacy of anti-fibrotic therapy with that of immunosuppressive treatment for patients with IPAF-UIP. Methods: In this retrospective case series, we identified consecutive IPAF-UIP patients treated with anti-fibrotic therapy or immunosuppressive therapy. Clinical characteristics, one-year treatment response, acute exacerbation, and survival were studied. We performed a stratified analysis by the pathological presence or absence of inflammatory cell infiltration. Results: Twenty-seven patients with anti-fibrotic therapy and 29 with immunosuppressive treatment were included. There was a significant difference in one-year forced vital capacity (FVC) change between patients with anti-fibrotic treatment (4 in 27 improved, 12 stable, and 11 worsened) and those with immunosuppressive treatment (16 in 29 improved, eight stable, and five worsened) (p = 0.006). There was also a significant difference in one-year St George's Respiratory Questionnaire (SGRQ) change between patients with anti-fibrotic therapy (2 in 27 improved, ten stable, and 15 worsened) and those with immunosuppressive treatment (14 in 29 improved, 12 stable, and worsened) (p < 0.001). There was no significant difference in survival between the groups (p = 0.32). However, in the subgroup with histological inflammatory cell infiltration, survival was significantly better with immunosuppressive therapy (p = 0.02). Conclusion: In IPAF-UIP, immunosuppressive therapy seemed to be superior to anti-fibrotic treatment in terms of therapeutic response, and provided better outcomes in the histological inflammatory subgroup. Further prospective studies are needed to clarify the therapeutic strategy in IPAF-UIP.

DOI： 10.1016/j.resinv.2023.01.007

Web of Science

Scopus

PubMed
Prevalence and prognosis of chronic fibrosing interstitial lung diseases with a progressive phenotype. Reviewed International journal

Reoto Takei, Kevin K Brown, Yasuhiko Yamano, Kensuke Kataoka, Toshiki Yokoyama, Toshiaki Matsuda, Tomoki Kimura, Atsushi Suzuki, Taiki Furukawa, Junya Fukuoka, Takeshi Johkoh, Yoshihito Goto, Yasuhiro Kondoh

Respirology (Carlton, Vic.) Vol. 27 ( 5 ) page： 333 - 340 2022.5

　More details

Language：English Publishing type：Research paper (scientific journal)

BACKGROUND AND OBJECTIVE: The development of clinically progressive fibrosis complicates a wide array of interstitial lung diseases (ILDs). However, there are limited data regarding its prevalence and prognosis. METHODS: We analysed consecutive patients seen for initial evaluation of a fibrosing form of ILD (FILD). Patients were evaluated for evidence of progressive fibrosis over the first 24 months of follow-up. We defined a progressive phenotype as the presence of at least one of the following: a relative decline in forced vital capacity (FVC) of ≥10%; a relative decline in FVC of ≥5%-<10% with a relative decline in diffusing capacity of the lung for carbon monoxide of ≥15%, increased fibrosis on HRCT or progressive symptoms. RESULTS: Eight hundred and forty-four patients (397 with idiopathic pulmonary fibrosis [IPF] and 447 non-IPF FILD) made up the final analysis cohort. Three hundred and fifty-five patients (42.1%) met the progressive phenotype criteria (59.4% of IPF patients and 26.6% of non-IPF FILD patients, p <0.01). In both IPF and non-IPF FILD, transplantation-free survival differed between patients with a progressive phenotype and those without (p <0.01). Multivariable analysis showed that a progressive phenotype was an independent predictor of transplantation-free survival (hazard ratio [HR]: 3.36, 95% CI: 2.68-4.23, p <0.01). Transplantation-free survival did not differ between non-IPF FILD with a progressive phenotype and IPF (HR: 1.12, 95% CI: 0.85-1.48, p = 0.42). CONCLUSION: Over one-fourth of non-IPF FILD patients develop a progressive phenotype compared to approximately 60% of IPF patients. The survival of non-IPF FILD patients with a progressive phenotype is similar to IPF.

DOI： 10.1111/resp.14245

Web of Science

Scopus

PubMed
The prognostic value of the COPD Assessment Test in fibrotic interstitial lung disease. Reviewed International journal

Toshiaki Matsuda, Yasuhiro Kondoh, Taiki Furukawa, Atsushi Suzuki, Reoto Takei, Hajime Sasano, Yasuhiko Yamano, Toshiki Yokoyama, Kensuke Kataoka, Tomoki Kimura

Respiratory investigation Vol. 60 ( 1 ) page： 99 - 107 2022.1

　More details

Language：English Publishing type：Research paper (scientific journal)

BACKGROUND: The COPD Assessment Test (CAT) has been studied as a measure of health status in idiopathic pulmonary fibrosis (IPF) and interstitial lung disease associated with connective tissue disease. However, its prognostic value is unknown. The present study explored the association between CAT score and mortality in fibrotic interstitial lung disease (FILD), including IPF and other forms of ILD. METHODS: We retrospectively analyzed 501 consecutive patients with FILD who underwent clinical assessment, including pulmonary function test and CAT. The association between CAT score and 3-year mortality was assessed using Cox proportional hazard analysis, Kaplan-Meier plots, and the log-rank test for trend. To handle missing data, the imputed method was used. RESULTS: The patients' median age was 68 years, and 320 were male (63.9%). Regarding CAT severity, 203 patients had a low impact level (score <10), 195 had a medium level (10-20), 80 had a high level (21-30), and 23 had a very high level (31-40). During the 3-year study period, 118 patients died. After adjusting for age, sex, forced vital capacity, diffusion capacity for carbon monoxide, IPF diagnosis, and usual interstitial pneumonia pattern on high-resolution computed tomography, the CAT score was significantly associated with 3-year mortality (hazard ratio in increments of 10 points: 1.458, 95% confidence interval 1.161-1.830; p < 0.001). In addition, patients with high and very high impact levels had twofold and threefold higher mortality risk than those with low levels, respectively. CONCLUSION: The CAT has prognostic value in FILD.

DOI： 10.1016/j.resinv.2021.07.007

Web of Science

Scopus

PubMed
新型コロナウイルス感染症(COVID-19)拡大におけるDPCデータを用いた受療状況分析 Reviewed

佐藤菊枝, 小林大介, 山下暁士, 大山慎太郎, 古川大記, 白鳥義宗

医療情報学連合大会論文集 Vol. 41回 page： 570 - 572 2021.11

　More details

Language：Japanese Publishing type：Research paper (conference, symposium, etc.) Publisher：(一社)日本医療情報学会
東海国立大学機構が実現しようとしているSociety5.0 Invited Reviewed

白鳥義宗, 大山慎太郎, 山下暁士, 佐藤菊枝, 小林大介, 舩田千秋, 古川大記, 菅野亜紀, 森龍太郎, 矢部大介

医療情報学連合大会論文集 Vol. 41回 page： 113 - 115 2021.11

　More details

Language：Japanese Publishing type：Research paper (international conference proceedings) Publisher：(一社)日本医療情報学会
The current issues and future perspective of artificial intelligence for developing new treatment strategy in non-small cell lung cancer: harmonization of molecular cancer biology and artificial intelligence. Reviewed International journal

Ichidai Tanaka, Taiki Furukawa, Masahiro Morise

Cancer cell international Vol. 21 ( 1 ) page： 454 - 454 2021.8

　More details

Language：English Publishing type：Research paper (scientific journal)

Comprehensive analysis of omics data, such as genome, transcriptome, proteome, metabolome, and interactome, is a crucial technique for elucidating the complex mechanism of cancer onset and progression. Recently, a variety of new findings have been reported based on multi-omics analysis in combination with various clinical information. However, integrated analysis of multi-omics data is extremely labor intensive, making the development of new analysis technology indispensable. Artificial intelligence (AI), which has been under development in recent years, is quickly becoming an effective approach to reduce the labor involved in analyzing large amounts of complex data and to obtain valuable information that is often overlooked in manual analysis and experiments. The use of AI, such as machine learning approaches and deep learning systems, allows for the efficient analysis of massive omics data combined with accurate clinical information and can lead to comprehensive predictive models that will be desirable for further developing individual treatment strategies of immunotherapy and molecular target therapy. Here, we aim to review the potential of AI in the integrated analysis of omics data and clinical information with a special focus on recent advances in the discovery of new biomarkers and the future direction of personalized medicine in non-small lung cancer.

DOI： 10.1186/s12935-021-02165-7

Web of Science

Scopus

PubMed
Prognosis in Non-IPF with Progressive Fibrotic Phenotype Results in Similar Prognosis in IPF Reviewed International journal

Ito T., Takei R., Sasano H., Yamano Y., Yokoyama T., Matsuda T., Kimura T., Furukawa T., Johkoh T., Fukuoka J., Kondoh Y.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE Vol. 203 ( 9 ) 2021.5

　More details

Language：Japanese Publishing type：Research paper (international conference proceedings)

Web of Science
Impact of post-capillary pulmonary hypertension on mortality in interstitial lung disease. Reviewed International journal

Ryo Teramachi, Hiroyuki Taniguchi, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka, Toshiki Yokoyama, Taiki Furukawa, Mitsuaki Yagi, Koji Sakamoto, Naozumi Hashimoto, Yoshinori Hasegawa

Respiratory investigation Vol. 59 ( 3 ) page： 342 - 349 2021.5

　More details

Language：English Publishing type：Research paper (scientific journal)

BACKGROUND: Pulmonary hypertension (PH) influences mortality in patients with interstitial lung disease (ILD). Almost all studies on patients with ILD, have focused on the clinical impact of pre-capillary PH on survival. Therefore, little is known about the influence of post-capillary PH. We aimed to assess the prevalence of post-capillary PH and its clinical impact on survival in patients with ILD, followed by comparison with pre-capillary PH. METHODS: This retrospective study enrolled 1152 patients with ILD who were diagnosed with PH using right heart catheterization between May 2007 and December 2015. We analyzed the demographics and composite outcomes (defined as death from any cause or lung transplantation) of patients with post-capillary PH and compared them with patients with pre-capillary PH. RESULTS: Thirty-two (20%) of the 157 patients with ILD-PH were diagnosed with post-capillary PH. Patients with post-capillary PH had significantly lower modified Medical Research Council scores, higher diffusion capacity for carbon monoxide, higher resting PaO2, lower pulmonary vascular resistance (PVR), and higher lowest oxygen saturation during the 6-min walk test compared to those with pre-capillary PH. Cardiovascular diseases were associated with a higher risk of mortality in patients with post-capillary PH. Multivariate Cox proportional hazards analysis demonstrated no significant difference between the composite outcomes in pre-capillary and post-capillary PH, while PVR and the ILD Gender-Age-Physiology Index were significantly associated with the composite outcome. CONCLUSIONS: We found that approximately one-fifth of patients with ILD-PH were diagnosed with post-capillary PH, and that PVR and not post-capillary PH was associated with mortality.

DOI： 10.1016/j.resinv.2020.12.010

Web of Science

Scopus

PubMed
Smart hospital infrastructure: geomagnetic in-hospital medical worker tracking. Reviewed International journal

Keiko Yamashita, Shintaro Oyama, Tomohiro Otani, Satoshi Yamashita, Taiki Furukawa, Daisuke Kobayashi, Kikue Sato, Aki Sugano, Chiaki Funada, Kensaku Mori, Naoki Ishiguro, Yoshimune Shiratori

Journal of the American Medical Informatics Association : JAMIA Vol. 28 ( 3 ) page： 477 - 486 2021.3

　More details

Language：English Publishing type：Research paper (scientific journal)

PURPOSE: Location visualization is essential for locating people/objects, improving efficiency, and preventing accidents. In hospitals, Wi-Fi, Bluetooth low energy (BLE) Beacon, indoor messaging system, and similar methods have generally been used for tracking, with Wi-Fi and BLE being the most common. Recently, nurses are increasingly using mobile devices, such as smartphones and tablets, while shifting. The accuracy when using Wi-Fi or BLE may be affected by interference or multipath propagation. In this research, we evaluated the positioning accuracy of geomagnetic indoor positioning in hospitals. MATERIALS AND METHODS: We compared the position measurement accuracy of a geomagnetic method alone, Wi-Fi alone, BLE beacons alone, geomagnetic plus Wi-Fi, and geomagnetic plus BLE in a general inpatient ward, using a geomagnetic positioning algorithm by GiPStech. The existing Wi-Fi infrastructure was used, and 20 additional BLE beacons were installed. Our first experiment compared these methods' accuracy for 8 test routes, while the second experiment verified a combined geomagnetic/BLE beacon method using 3 routes based on actual daily activities. RESULTS: The experimental results demonstrated that the most accurate method was geomagnetic/BLE, followed by geomagnetic/Wi-Fi, and then geomagnetic alone. DISCUSSION: The geomagnetic method's positioning accuracy varied widely, but combining it with BLE beacons reduced the average position error to approximately 1.2 m, and the positioning accuracy could be improved further. We believe this could effectively target humans (patients) where errors of up to 3 m can generally be tolerated. CONCLUSION: In conjunction with BLE beacons, geomagnetic positioning could be sufficiently effective for many in-hospital localization tasks.

DOI： 10.1093/jamia/ocaa204

Web of Science

Scopus

PubMed
Serum mitochondrial DNA predicts the risk of acute exacerbation and progression of idiopathic pulmonary fibrosis. Reviewed International coauthorship International journal

Koji Sakamoto, Taiki Furukawa, Yasuhiko Yamano, Kensuke Kataoka, Ryo Teramachi, Anjali Walia, Atsushi Suzuki, Masahide Inoue, Yoshio Nakahara, Changwan Ryu, Naozumi Hashimoto, Yasuhiro Kondoh

The European respiratory journal Vol. 57 ( 1 ) 2021.1

　More details

Authorship：Lead author Language：English Publishing type：Research paper (scientific journal)

DOI： 10.1183/13993003.01346-2020

Web of Science

Scopus

PubMed
Hand hygiene monitoring by positioning technology utilizing IoT devices. Reviewed International journal

Keiko Yamashita, Shintaro Oyama, Satoshi Yamashita, Chiaki Funada, Kikue Sato, Taiki Furukawa, Aki Sugano, Daisuke Kobayashi, Hiroshi Tomozawa, Yuji Sakamoto, Yoshinori Ideno, Kensaku Mori, Yoshimune Shiratori

AMIA 2021

　More details

Language：English Publishing type：Research paper (international conference proceedings)

Other Link： https://dblp.uni-trier.de/rec/conf/amia/2021

▼display all

To the head of Papers.▲

Books 10

呼吸器内科学レビュー 2024-’25

古川大記（ Role： Contributor , 間質性肺炎診療と新テクノロジー）

総合医学社 2023.11

　More details

Language：Japanese
【最新主要文献とガイドラインでみる呼吸器内科学レビュー 2024-'25】(XIV章)新テクノロジーと肺疾患間質性肺炎診療と新テクノロジー

古川大記（ Role： Contributor）

(株)総合医学社 2023.11 （ ISBN:9784883784769 ）

　More details

Language：Japanese Book type：Scholarly book

＜最近の研究動向とガイドライン＞●間質性肺疾患(interstitial lung disease:ILD)では,臨床的な知識・判断を補助する医療ソフトウェアアルゴリズムの発展,クライオバイオプシーをはじめとする内視鏡の開発と臨床応用,ウェアラブルデバイスを用いた疾病管理の研究開発,などテクノロジーの発展が進んでいる.●執筆時点(2023年7月)の一般社会では,Chat GPTに代表される大規模言語モデル(large language models:LLM)を用いた人工知能(AI)が物凄い速さで普及しているが,形態学的な特徴を捉えることが有用であるILDでは,胸部放射線画像や病理画像から疾患の特徴を捉えるAIの一種である機械学習や,機械学習の一種である深層学習の研究開発が進んできた.●また,ILDの診療に目を向けると,本邦では全国規模のILDレジストリが進行中であり,遠隔医療とAIを実臨床に応用できる可能性が期待されている.●本稿では,特にILDの診療におけるテクノロジーの発展を主眼に,近年の動向を述べる.(著者抄録)
間質性肺炎のレジストリ研究

古川大記（ Role： Contributor）

(有)科学評論社 2022.12

　More details

Language：Japanese Book type：Scholarly book
呼吸器内科間質性肺疾患のAI画像診断の開発状況と今後の展望について実臨床で使用できるようにAI開発とシステム構築が進められている

古川大記, 伊藤健太郎

(株)日本医事新報社 2022.10

　More details

Language：Japanese Book type：Scholarly book
【びまん性肺疾患における多職種合議(MDD)診断とAI支援の現在と未来】MDD診断へのAI「画像診断」支援の現状と可能性について

古川大記, 寺町涼（ Role： Contributor）

(有)科学評論社 2022.2

　More details

Language：Japanese Book type：Scholarly book
肺線維症の病態に関連する2つの新規マーカー分子:メフリンとミトコンドリアDNA

阪本考司, 橋本直純, 中原義夫, 古川大記（ Role： Contributor）

(有)科学評論社 2022.2

　More details

Language：Japanese Book type：Scholarly book
間質性肺炎診療と新テクノロジー

古川大記（ Role： Sole author）

呼吸器内科学レビュー 2022-’23 2021.12

　More details

Language：Japanese Book type：Scholarly book
【最新主要文献とガイドラインでみる呼吸器内科学レビュー 2022-'23】(XIV章)新テクノロジーと肺疾患間質性肺炎診療と新テクノロジー

古川大記

(株)総合医学社 2021.12 （ ISBN:9784883787470 ）

　More details

Language：Japanese Book type：Scholarly book

間質性肺炎(ILD)の正確な診断には、呼吸器内科医、放射線科医、病理医の集学的議論(MDD)、外科的肺生検やクライオバイオプシーが重要であるが、近年、新しいテクノロジーを用いた診療が広がりつつある。機械学習と深層学習を用いたILDの画像所見の抽出、ゲノム評価、診断と治療効果予測について概説した。また、間質性肺炎のAI(人工知能)創薬、遠隔診療(オンラインMDD診断)、在宅モニタリングと呼吸器リハビリテーションについて述べた。
間質性肺炎のAI診断

古川大記, 大山慎太郎（ Role： Joint author）

呼吸器ジャーナル 2021.8

　More details

Language：Japanese Book type：Scholarly book
【間質性肺炎徹底討論!-鳥からは逃げられない過敏性肺炎,放置してよいのかILA】最近の話題間質性肺炎のAI診断

古川大記, 大山慎太郎（ Role： Contributor）

(株)医学書院 2021.8 （ ISBN:9784260029087 ）

　More details

Language：Japanese Book type：Scholarly book

＜文献概要＞Point ・テクノロジーの発展に伴って医療AIも開発されてきたが,臨床応用は注意が必要である.・間質性肺炎の画像特徴を捉えるAIから,診断・予後予測AIも開発されてきた.・全国規模の間質性肺炎レジストリが進行中であり,様々な研究結果が期待される.

Other Link： https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2021&ichushi_jid=J06862&link_issn=&doc_id=20210813210020&doc_link_id=10.11477%2Fmf.1437200484&url=https%3A%2F%2Fdoi.org%2F10.11477%2Fmf.1437200484&type=%88%E3%8F%91.jp_%83I%81%5B%83%8B%83A%83N%83Z%83X&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00024_2.gif

▼display all

To the head of Books.▲

MISC 18

ロボット支援下手術における患者受療動向と地域医療への影響評価 Reviewed

佐藤菊枝, 小林大介, 古川大記, 白鳥義宗

医療情報学連合大会論文集 Vol. 43回 page： 1172 - 1174 2023.11

　More details

Language：Japanese Publishing type：Research paper, summary (national, other academic conference) Publisher：(一社)日本医療情報学会
In-Hospital Cancer Mortality Prediction by Multimodal Learning of Non-English Clinical Texts. Reviewed International journal

Shintaro Oyama, Taiki Furukawa, Shotaro Misawa, Ryuji Kano, Hirokazu Yarimizu, Tomoki Taniguchi, Kohei Onoda, Kikue Sato, Yoshimune Shiratori

Studies in health technology and informatics Vol. 302 page： 821 - 822 2023.5

　More details

Language：English Publishing type：Article, review, commentary, editorial, etc. (international conference proceedings)

Predicting important outcomes in patients with complex medical conditions using multimodal electronic medical records remains challenge. We trained a machine learning model to predict the inpatient prognosis of cancer patients using EMR data with Japanese clinical text records, which has been considered difficult due to its high context. We confirmed high accuracy of the mortality prediction model using clinical text in addition to other clinical data, suggesting applicability of this method to cancer.

DOI： 10.3233/SHTI230276

Scopus

PubMed
Sentence Extraction using Outcome Prediction Model Trained from Clinical Data Reviewed

MISAWA Shotaro, FURUKAWA Taiki, OYAMA Shintaro, KANO Ryuji, YARIMIZU Hirokazu, TANIGUCHI Tomoki, ONODA Kohei, SATO Kikue, SHIRATORI Yoshimune

Proceedings of the Annual Conference of JSAI Vol. JSAI2023 ( 0 ) page： 3Xin404 - 3Xin404 2023

　More details

Language：Japanese Publishing type：Research paper, summary (national, other academic conference) Publisher：The Japanese Society for Artificial Intelligence

<p>This study aims to extract clinically important sentences from accumulated medical documents to assist medical workers to search documents. Unsupervised document summarization methods such as LexRank are commonly used in situations where it is difficult to prepare training data. However, these methods are based on a hypothesis that important topics are frequently referred which does not match the medical document. Many previous studies have predicted the length of hospital stay and mortality using clinical data, and we propose these outcomes can be distant labels of clinical importance. Namely, an output from the outcome prediction model becomes high when an input sentence is clinically important. Therefore, in this study, we propose a model to extract clinically important sentences using an outcome prediction model. Experimental results show our text extraction model with an outcome prediction model can summarize more accurately than the conventional models.</p>

DOI： 10.11517/pjsai.jsai2023.0_3xin404

CiNii Research
間質性肺炎のレジストリ研究

古川大記

呼吸器内科 Vol. 42 ( 6 ) page： 654 - 657 2022.12

　More details

Authorship：Lead author,　Last author,　Corresponding author Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (scientific journal) Publisher：(有)科学評論社
呼吸器内科間質性肺疾患のAI画像診断の開発状況と今後の展望について実臨床で使用できるようにAI開発とシステム構築が進められている

古川大記, 伊藤健太郎

日本医事新報 ( 5136 ) page： 48 - 49 2022.10

　More details

Authorship：Lead author,　Corresponding author Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (trade magazine, newspaper, online media) Publisher：(株)日本医事新報社
【びまん性肺疾患における多職種合議(MDD)診断とAI支援の現在と未来】MDD診断へのAI「画像診断」支援の現状と可能性について

古川大記, 寺町涼

呼吸器内科 Vol. 41 ( 2 ) page： 180 - 184 2022.2

　More details

Authorship：Lead author,　Last author,　Corresponding author Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (scientific journal) Publisher：(有)科学評論社
肺線維症の病態に関連する2つの新規マーカー分子:メフリンとミトコンドリアDNA

阪本考司, 橋本直純, 中原義夫, 古川大記

呼吸器内科 Vol. 41 ( 2 ) page： 197 - 201 2022.2

　More details

Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (scientific journal) Publisher：(有)科学評論社
MDD診断へのAI「画像診断」支援の現状と可能性について. Invited

古川大記

呼吸器内科 Vol. 41(2) page： 180 - 184 2022

　More details

Authorship：Lead author,　Last author,　Corresponding author Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (trade magazine, newspaper, online media)

CiNii Research
【最新主要文献とガイドラインでみる呼吸器内科学レビュー 2022-'23】(XIV章)新テクノロジーと肺疾患間質性肺炎診療と新テクノロジー

古川大記

呼吸器内科学レビュー Vol. 2022-'23 page： 327 - 332 2021.12

　More details

Authorship：Lead author,　Last author,　Corresponding author Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (scientific journal) Publisher：(株)総合医学社

間質性肺炎(ILD)の正確な診断には、呼吸器内科医、放射線科医、病理医の集学的議論(MDD)、外科的肺生検やクライオバイオプシーが重要であるが、近年、新しいテクノロジーを用いた診療が広がりつつある。機械学習と深層学習を用いたILDの画像所見の抽出、ゲノム評価、診断と治療効果予測について概説した。また、間質性肺炎のAI(人工知能)創薬、遠隔診療(オンラインMDD診断)、在宅モニタリングと呼吸器リハビリテーションについて述べた。
東海国立大学機構が実現しようとしているSociety5.0 Reviewed

白鳥義宗, 大山慎太郎, 山下暁士, 佐藤菊枝, 小林大介, 舩田千秋, 古川大記, 菅野亜紀, 森龍太郎, 矢部大介

医療情報学連合大会論文集 Vol. 41回 page： 113 - 115 2021.11

　More details

Language：Japanese Publishing type：Research paper, summary (national, other academic conference) Publisher：(一社)日本医療情報学会
特集間質性肺炎徹底討論!-鳥からは逃げられない過敏性肺炎,放置してよいのかILA Ⅳ.最近の話題間質性肺炎のAI診断

古川大記, 大山慎太郎

呼吸器ジャーナル Vol. 69 ( 3 ) page： 450 - 457 2021.8

　More details

Authorship：Lead author,　Corresponding author Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (trade magazine, newspaper, online media) Publisher：株式会社　医学書院

DOI： 10.11477/mf.1437200484

CiNii Research
Prognosis in Non-IPF with Progressive Fibrotic Phenotype Results in Similar Prognosis in IPF Reviewed International journal

Ito T., Takei R., Sasano H., Yamano Y., Yokoyama T., Matsuda T., Kimura T., Furukawa T., Johkoh T., Fukuoka J., Kondoh Y.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE Vol. 203 ( 9 ) 2021.5

　More details

Language：English Publishing type：Research paper, summary (international conference)

Web of Science
間質性肺疾患における肺高血圧予測モデルの構築 Reviewed

佐藤智則, 古川大記, 寺町涼, 山野泰彦, 横山俊樹, 松田俊明, 片岡健介, 木村智樹, 近藤康博

日本呼吸器学会誌 Vol. 10 ( 増刊 ) page： 225 - 225 2021.4

　More details

Language：Japanese Publishing type：Research paper, summary (national, other academic conference) Publisher：(一社)日本呼吸器学会
Construction of a data collection platform based on the regional medical care data infrastructure Reviewed

佐藤菊枝, 小林大介, 小林大介, 山下暁士, 大山慎太郎, 古川大記, 白鳥義宗

日本医療情報学会春季学術大会プログラム・抄録集 Vol. 25th 2021

　More details

J-GLOBAL
Outcome prediction using Integrated Clinical Database toward Automatic Generation of Clinical Summaries Reviewed

古川大記, 三沢翔太郎, 大山慎太郎, 佐藤菊枝, 狩野竜示, 鑓水大和, 白鳥義宗

医療情報学連合大会論文集(CD-ROM) Vol. 41st 2021

　More details

Authorship：Lead author,　Corresponding author Language：Japanese Publishing type：Research paper, summary (national, other academic conference)

J-GLOBAL
Patient access analysis in COVID-19 Pandemic using DPC data Reviewed

佐藤菊枝, 小林大介, 小林大介, 山下暁士, 大山慎太郎, 古川大記, 白鳥義宗

医療情報学連合大会論文集(CD-ROM) Vol. 41st 2021

　More details

Language：Japanese Publishing type：Research paper, summary (national, other academic conference)

J-GLOBAL
スマートホスピタル構想~医療Society5.0におけるDx研究~ Reviewed

大山慎太郎, 大山慎太郎, 古川大記, 古川大記, 山下暁士, 山下暁士, 原武史, 原武史

医療情報学連合大会論文集(CD-ROM) Vol. 41st 2021

　More details

Language：Japanese Publishing type：Research paper, summary (national, other academic conference)

J-GLOBAL
間質性肺炎診療と新テクノロジー

古川大記

最新主要文献とガイドラインでみる　呼吸器内科学レビュー 2022-’23 Vol. - page： 327 - 332 2021

　More details

Authorship：Lead author,　Last author,　Corresponding author Language：Japanese Publishing type：Book review, literature introduction, etc.

CiNii Research

▼display all

To the head of MISC.▲

Presentations 51

Nationwide All ILD registry with central MDD in Japan; Providing Multidisciplinary ILD diagnoses (PROMISE) study. International conference

T. Furukawa, Y. Kondoh, S. Oyama, R. Teramachi, H. Hozumi, T. Suda, T. Fujisawa, R. Egashira, T. Johkoh, J. Fukuoka, K. Kataoka, H. Kitamura, O. Nishiyama, M. Okamoto, N. Koshimizu, N. Ishikawa, S. Okamori, Y. Miyazaki, M. Bando, Y. Inoue, T. Ogura, M. Kuwana, H. Tomioka, Y. Nishioka, H. Chiba, M. Ebina, K. Ichikado, Y. Nakanishi, N. Hashimoto, Y. Shiratori, Y. Hasegawa, M. Ishii, The Providing Multidisciplinary ILD Diagnoses [promise] Study Group

ERS International Congress 2023 2023.9.10

　More details

Event date： 2023.9

Language：English Presentation type：Oral presentation (general)
MDD診断とAI診療支援の現状と今後の展望 Invited

古川大記

日本呼吸器学会 2023.4.28 (一社)日本呼吸器学会

　More details

Event date： 2023.4

Language：Japanese Presentation type：Symposium, workshop panel (nominated)
間質性肺炎MDD 診断と予後予測の立場から Invited

古川大記

第2回日本びまん性肺疾患研究会 2022.10.2

　More details

Event date： 2022.10

Language：Japanese Presentation type：Symposium, workshop panel (nominated)
間質性肺炎の診断・予後予測アルゴリズム構築と社会実装に向けて Invited

古川大記

ARO協議会第9回学術集会 2022.9.16

　More details

Event date： 2022.9

Language：Japanese Presentation type：Symposium, workshop panel (nominated)
Development of AI models to predict mortality and long-term hospitalization in pneumonia International conference

Taiki Furukawa, Shintaro Oyama, Kikue Sato, Shotaro Misawa, Ryuji Kano, Hirokazu Yarimizu, Yoshimmune Shiratori

ERS International Congress 2022 2022.9.6

　More details

Event date： 2022.9

Language：English Presentation type：Oral presentation (general)
医療用AIとアルゴリズムの構築 Invited

古川大記

第7回日本肺高血圧・肺循環学会学術集会 2022.7.3

　More details

Event date： 2022.7

Language：Japanese Presentation type：Oral presentation (invited, special)
IPFのAI診断の現状と問題点 Invited

古川大記

第62回日本呼吸器学会学術集会 2022.4.24

　More details

Event date： 2022.4

Language：Japanese Presentation type：Symposium, workshop panel (nominated)
びまん性肺疾患MDD診断の為の双方向性Webプラットフォーム構築と人工知能診断の社会実装に関する前向き研究 Invited

古川大記

第62回日本呼吸器学会学術集会 2022.4.23

　More details

Event date： 2022.4

Language：Japanese Presentation type：Oral presentation (invited, special)
Interstitial lung disease and BIG-DATA / AI Invited

Taiki Furukawa

The 61st Annual Meeting of The Japanese Respiratory Society 2021.4.24

　More details

Event date： 2021.4

Language：Japanese Presentation type：Oral presentation (invited, special)
医療者テキスト情報を活用した機械学習によるICU 患者の包括的予後予測

古川大記, 三沢翔太郎, 大山慎太郎, 鑓水大和, 小野田浩平, 佐藤菊枝, 白鳥義宗

第51回日本集中医療学会学術集会 2024.3.14

　More details

Event date： 2024.3

Language：Japanese Presentation type：Oral presentation (general)
呼吸器領域におけるAIの現在と今後の展望 Invited

古川大記

日本内科学会東海地方会第35回教育セミナー 2023.10.15

　More details

Event date： 2023.10

Language：Japanese Presentation type：Public lecture, seminar, tutorial, course, or other speech
PROMISE試験からみたびまん性肺疾患リアルワールドデータの現状と課題 Invited

古川大記, 寺町涼

第3回日本びまん性肺疾患研究会 2023.9.30

　More details

Event date： 2023.9 - 2023.10

Language：Japanese Presentation type：Symposium, workshop panel (nominated)
びまん性肺疾患の集学的合議(MDD)におけるTime Study

佐藤大介, 古川大記, 小林大介, 上甲剛, 福岡順也, 近藤康博

第3回日本びまん性肺疾患研究会 2023.10.1

　More details

Event date： 2023.9 - 2023.10

Language：Japanese Presentation type：Oral presentation (general)
Diagnostic Criteria Arrangement in Nationwide All ILD Registry with Central MDD in Japan; PROMISE study International conference

Y. Kondoh, T. Furukawa, R. Teramachi, H. Hozumi, T. Suda, T. Fujisawa, R. Egashira, T. Johkoh, J. Fukuoka, M. Kuwana, T. Ogura, Y. Miyazaki, M. Bando, Y. Inoue, H. Tomioka, Y. Nishioka, H. Chiba, M. Ebina, K. Ichikado, N. Hashimoto, M. Ishii

ERS International Congress 2023 2023.9.10

　More details

Event date： 2023.9

Language：English Presentation type：Poster presentation
Diagnostic Criteria Arrangement in Nationwide All ILD Registry with Central MDD in Japan; PROMISE study International conference

Kondoh, Y; Furukawa, T; Teramachi, R; Hozumi, H; Suda, T; Fujisawa, T; Egashira, R; Johkoh, T; Fukuoka, J; Kuwana, M; Ogura, T; Miyazaki, Y; Bando, M; Inoue, Y; Tomioka, H; Nishioka, Y; Chiba, H; Ebina, M; Ichikado, K; Hashimoto, N; Ishii, M

EUROPEAN RESPIRATORY JOURNAL 2023.9.9

　More details

Event date： 2023.9

Language：English Presentation type：Poster presentation

DOI： 10.1183/13993003.congress2023.PA434
Nationwide All ILD registry with central MDD in Japan; Providing Multidisciplinary ILD diagnoses (PROMISE) study. International conference

Furukawa, T; Kondoh, Y; Oyama, S; Teramachi, R; Hozumi, H; Suda, T; Fujisawa, T; Egashira, R; Johkoh, T; Fukuoka, J; Kataoka, K; Kitamura, H; Nishiyama, O; Okamoto, M; Koshimizu, N; Ishikawa, N; Okamori, S; Miyazaki, Y; Bando, M; Inoue, Y; Ogura, T; Kuwana, M; Tomioka, H; Nishioka, Y; Chiba, H; Ebina, M; Ichikado, K; Nakanishi, Y; Hashimoto, N; Shiratori, Y; Hasegawa, Y; Ishii, M

EUROPEAN RESPIRATORY JOURNAL 2023.9.9

　More details

Event date： 2023.9

Language：English Presentation type：Oral presentation (general)

DOI： 10.1183/13993003.congress-2023.OA1424
mtDNA in bronchoalveolar lavage fluid is a prognostic factor for IPF and AE-IPF International conference

Fukihara, J; Sakamoto, K; Furukawa, T; Teramachi, R; Ikeyama, Y; Kataoka, K; Kondoh, Y; Hashimoto, N; Ishii, M

EUROPEAN RESPIRATORY JOURNAL 2023.9.9

　More details

Event date： 2023.9

Language：English Presentation type：Poster presentation

DOI： 10.1183/13993003.congress-2023.PA1236
機械学習による院内死亡予測モデルの特性分析

古川大記, 三沢翔太郎, 大山慎太郎, 狩野竜示, 鑓水大和, 谷口友紀, 小野田浩平, 佐藤菊枝, 白鳥義宗

第27回日本医療情報学会春季学術大会 2023.7.1

　More details

Event date： 2023.6 - 2023.7

Language：Japanese Presentation type：Oral presentation (general)
診療データを用いた予測モデルによる文抽出

三沢翔太郎, 古川大記, 大山慎太郎, 狩野竜示, 鑓水大和, 谷口友紀, 小野田浩平, 佐藤菊枝, 白鳥義宗

第37回人工知能学会全国大会 2023.6.9

　More details

Event date： 2023.6

Language：Japanese Presentation type：Poster presentation
入院時プロファイルと大気汚染物質による予後予測因子

佐藤菊枝, 古川大記, 小林大介, 山下暁士, 白鳥義宗

日本医療情報学会春季学術大会 2023.6 (一社)日本医療情報学会

　More details

Event date： 2023.6

Language：Japanese
機械学習による院内死亡予測モデルの特性分析

古川大記, 三沢翔太郎, 大山慎太郎, 狩野竜示, 鑓水大和, 谷口友紀, 小野田浩平, 佐藤菊枝, 白鳥義宗

日本医療情報学会春季学術大会プログラム・抄録集 2023.6 (一社)日本医療情報学会

　More details

Event date： 2023.6

Language：Japanese Presentation type：Oral presentation (general)
Prognostic factors for Covid-19 on admission profile and air pollutants International conference

Kikue Sato, Taiki Furukawa, Satoshi Yamashita, Daisuke Kobayashi, Shintaro Oyama, Yoshimune Shiratori

Medical Informatics Europe 2023 2023.5.22

　More details

Event date： 2023.5

Language：English Presentation type：Poster presentation
In-Hospital Mortality Prediction by Multimodal Learning of non-English Clinical Texts

Shintaro Oyama, Taiki Furukawa, Shotaro Misawa, Ryuji Kano, Hirokazu Yarimizu, Tomoki Taniguchi, Kohei Onoda, Kikue Sato, Yoshimune Shiratori

Medical Informatics Europe 2023 2023.5.22

　More details

Event date： 2023.5

Language：English Presentation type：Poster presentation
機械学習を活用した抗PD-1/PD-L1抗体治療の生存予測バイオマーカー構築

神山潤二, 森瀬昌宏, 古川大記, 阪本考司, 松下明弘, 松尾正樹, 浅野周一, 田中太郎, 島浩一郎, 木村智樹, 近藤康博, 石井誠

第63回日本呼吸器学会学術集会 2023.4.28

　More details

Event date： 2023.4

Language：Japanese Presentation type：Oral presentation (general)
Artificial intelligence-based personalized survival prediction using clinical and radiomics features in patients with advanced non-small cell lung cancer International conference

Koyama, J; Morise, M; Furukawa, T; Oyama, S; Matsuzawa, R; Tanaka, I; Wakahara, K; Yokota, H; Kimura, T; Shiratori, Y; Kondoh, Y; Hashimoto, N

RESPIROLOGY 2023.2

　More details

Event date： 2023.2

Language：English Presentation type：Oral presentation (general)
Artificial intelligence-based personalized survival prediction using clinical and radiomics features in patients with advanced non-small cell lung cancer International conference

Koyama, J; Morise, M; Furukawa, T; Oyama, S; Matsuzawa, R; Tanaka, I; Wakahara, K; Yokota, H; Kimura, T; Shiratori, Y; Kondoh, Y; Hashimoto, N

RESPIROLOGY 2023.2

　More details

Event date： 2023.2

Language：English Presentation type：Oral presentation (general)
Artificial intelligence-based personalized survival prediction using clinical and radiomics features in patients with advanced non-small cell lung cancer International conference

Koyama, J; Morise, M; Furukawa, T; Oyama, S; Matsuzawa, R; Tanaka, I; Wakahara, K; Yokota, H; Kimura, T; Shiratori, Y; Kondoh, Y; Hashimoto, N

RESPIROLOGY 2023.2

　More details

Event date： 2023.2

Language：English Presentation type：Symposium, workshop panel (nominated)
Artificial intelligence-based personalized survival prediction using clinical and radiomics features in patients with advanced non-small cell lung cancer International conference

Koyama, J; Morise, M; Furukawa, T; Oyama, S; Matsuzawa, R; Tanaka, I; Wakahara, K; Yokota, H; Kimura, T; Shiratori, Y; Kondoh, Y; Hashimoto, N

RESPIROLOGY 2023.2

　More details

Event date： 2023.2

Language：English Presentation type：Oral presentation (general)
Artificial intelligence-based personalized survival prediction using clinical and radiomics features in patients with advanced non-small cell lung cancer International conference

Koyama, J; Morise, M; Furukawa, T; Oyama, S; Matsuzawa, R; Tanaka, I; Wakahara, K; Yokota, H; Kimura, T; Shiratori, Y; Kondoh, Y; Hashimoto, N

RESPIROLOGY 2023.2

　More details

Event date： 2023.2

Language：English Presentation type：Oral presentation (general)
In-Hospital Cancer Mortality Prediction by Multimodal Learning of Non-English Clinical Texts. International conference

Shintaro Oyama, Taiki Furukawa, Shotaro Misawa, Ryuji Kano, Hirokazu Yarimizu, Tomoki Taniguchi, Kohei Onoda, Kikue Sato, Yoshimune Shiratori

Studies in health technology and informatics 2023

　More details

Event date： 2023

Language：English Presentation type：Poster presentation

Predicting important outcomes in patients with complex medical conditions using multimodal electronic medical records remains challenge. We trained a machine learning model to predict the inpatient prognosis of cancer patients using EMR data with Japanese clinical text records, which has been considered difficult due to its high context. We confirmed high accuracy of the mortality prediction model using clinical text in addition to other clinical data, suggesting applicability of this method to cancer.

DOI： 10.3233/SHTI230276

Scopus

PubMed
進行非小細胞肺癌における臨床および画像特徴量を用いた機械学習による個別化生存予測モデルの構築

神山潤二, 森瀬昌宏, 古川大記, 松澤令子, 田中一大, 横田秀夫, 木村智樹, 近藤康博, 橋本直純

第63回日本肺癌学会学術集会 2022.12.3

　More details

Event date： 2022.12

Language：Japanese Presentation type：Oral presentation (general)
Artificial intelligence-based personalized survival prediction using clinical and radiomics features in patients with advanced non-small cell lung cancer International conference

Junji Koyama, Masahiro Morise, Taiki Furukawa, Shintaro Oyama, Reiko Matsuzawa, Ichidai Tanaka, Keiko Wakahara, Hideo Yokota, Tomoki Kimura, Yoshimune Shiratori, Yasuhiro Kondoh, Naozumi Hashimoto

The 26th Congress of the Asian Pacific Society of Respirology 2022.11.18

　More details

Event date： 2022.11

Language：English Presentation type：Oral presentation (general)
新型コロナウイルス感染症(COVID-19)患者の入院時プロファイルからの予後予測

佐藤菊枝, 古川大記, 小林大介, 山下暁士, 白鳥義宗

第42回医療情報学連合大会 2022.11.20 (一社)日本医療情報学会

　More details

Event date： 2022.11

Language：Japanese Presentation type：Poster presentation
機械学習を用いたERCP後膵炎リスク予測モデルの構築

高橋秀和, 古川大記, 大野栄三郎, 石川卓哉, 水谷泰之, 飯田忠, 鈴木貴久, 川嶋啓揮

Japan Digestive Disease Week 2022 2022.10.28

　More details

Event date： 2022.10

Language：Japanese Presentation type：Poster presentation
Development of AI models to predict mortality and long-term hospitalization in pneumonia International conference

Furukawa, T; Oyama, S; Sato, K; Misawa, S; Kano, R; Yarimizu, H; Shiratori, Y

EUROPEAN RESPIRATORY JOURNAL 2022.9.4

　More details

Event date： 2022.9

Language：English Presentation type：Oral presentation (general)

DOI： 10.1183/13993003.congress-2022.342
時系列情報から間質性肺炎急性増悪発症及び予後を予測する深層学習モデルの構築

寺町涼, 古川大記, 大山慎太郎, 近藤康博, 烏山昌幸, 片岡健介, 白鳥義宗

第4回日本メディカルAI学会学術集会 2022.6.10

　More details

Event date： 2022.6

Language：Japanese Presentation type：Oral presentation (general)
進行非小細胞肺癌に対する薬物療法後の個別化生存予測における機械学習の活用

神山潤二, 森瀬昌宏, 古川大記, 大山慎太郎, 松澤令子, 田中一大, 若原恵子, 横田秀夫, 木村智樹, 白鳥義宗, 近藤康博, 橋本直純

第4回日本メディカルAI学会学術集会 2022.6.10

　More details

Event date： 2022.6

Language：Japanese Presentation type：Oral presentation (general)
統合診療データを用いたAIによるアウトカム予測と診療サマリ生成に向けた検討

古川大記, 三沢翔太郎, 大山慎太郎, 佐藤菊枝, 狩野竜示, 鑓水大和, 白鳥義宗

第41回医療情報学連合大会 2021.11.20

　More details

Event date： 2021.11

Presentation type：Oral presentation (general)
東海国立大学機構が実現しようとしているSociety5.0

白鳥義宗, 大山慎太郎, 山下暁士, 佐藤菊枝, 小林大介, 舩田千秋, 古川大記, 菅野亜紀, 森龍太郎, 矢部大介

医療情報学連合大会論文集 2021.11 (一社)日本医療情報学会

　More details

Event date： 2021.11

Language：Japanese Presentation type：Symposium, workshop panel (nominated)
Prognosis in Non-IPF with Progressive Fibrotic Phenotype Results in Similar Prognosis in IPF International conference

Ito, T; Takei, R; Sasano, H; Yamano, Y; Yokoyama, T; Matsuda, T; Kimura, T; Furukawa, T; Johkoh, T; Fukuoka, J; Kondoh, Y

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2021.5.1

　More details

Event date： 2021.5

Language：English Presentation type：Poster presentation
Prognosis in Non-IPF with Progressive Fibrotic Phenotype Results in Similar Prognosis in IPF International conference

Ito, T; Takei, R; Sasano, H; Yamano, Y; Yokoyama, T; Matsuda, T; Kimura, T; Furukawa, T; Johkoh, T; Fukuoka, J; Kondoh, Y

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2021.5.1

　More details

Event date： 2021.5

Language：English Presentation type：Poster presentation
Prognosis in Non-IPF with Progressive Fibrotic Phenotype Results in Similar Prognosis in IPF International conference

Ito, T; Takei, R; Sasano, H; Yamano, Y; Yokoyama, T; Matsuda, T; Kimura, T; Furukawa, T; Johkoh, T; Fukuoka, J; Kondoh, Y

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2021.5.1

　More details

Event date： 2021.5

Language：English Presentation type：Poster presentation
Prognosis in Non-IPF with Progressive Fibrotic Phenotype Results in Similar Prognosis in IPF International conference

Ito, T; Takei, R; Sasano, H; Yamano, Y; Yokoyama, T; Matsuda, T; Kimura, T; Furukawa, T; Johkoh, T; Fukuoka, J; Kondoh, Y

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2021.5.1

　More details

Event date： 2021.5

Language：English Presentation type：Poster presentation
Prognosis in Non-IPF with Progressive Fibrotic Phenotype Results in Similar Prognosis in IPF International conference

Ito, T; Takei, R; Sasano, H; Yamano, Y; Yokoyama, T; Matsuda, T; Kimura, T; Furukawa, T; Johkoh, T; Fukuoka, J; Kondoh, Y

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2021.5.1

　More details

Event date： 2021.5

Language：English Presentation type：Poster presentation
間質性肺疾患における肺高血圧予測モデルの構築

佐藤智則, 古川大記, 寺町涼, 山野泰彦, 横山俊樹, 松田俊明, 片岡健介, 木村智樹, 近藤康博

日本呼吸器学会 2021.4 (一社)日本呼吸器学会

　More details

Event date： 2021.4

Language：Japanese Presentation type：Oral presentation (general)
スマートホスピタル構想~医療Society5.0におけるDx研究~

大山慎太郎, 大山慎太郎, 古川大記, 古川大記, 山下暁士, 山下暁士, 原武史, 原武史

医療情報学連合大会 2021

　More details

Event date： 2021

Language：Japanese Presentation type：Symposium, workshop panel (nominated)
Outcome prediction using Integrated Clinical Database toward Automatic Generation of Clinical Summaries

古川大記, 三沢翔太郎, 大山慎太郎, 佐藤菊枝, 狩野竜示, 鑓水大和, 白鳥義宗

2021

　More details

Event date： 2021

Language：Japanese Presentation type：Oral presentation (general)
Patient access analysis in COVID-19 Pandemic using DPC data

佐藤菊枝, 小林大介, 小林大介, 山下暁士, 大山慎太郎, 古川大記, 白鳥義宗

医療情報学連合大会 2021

　More details

Event date： 2021

Language：Japanese Presentation type：Poster presentation
Construction of a data collection platform based on the regional medical care data infrastructure

佐藤菊枝, 小林大介, 小林大介, 山下暁士, 大山慎太郎, 古川大記, 白鳥義宗

2021

　More details

Event date： 2021

Language：Japanese Presentation type：Oral presentation (general)
Expanding Features of Outcome Prediction using Estimated Hospitalization Progress.

MISAWA Shotaro, FURUKAWA Taiki, OYAMA Shintaro, SATO Kikue, KANO Ryuji, YARIMIZU Hirokazu, TANIGUCHI Tomoki, ONODA Kohei, OHKUMA Tomoko, SHIRATORI Yoshimune

Proceedings of the Annual Conference of JSAI 2022 The Japanese Society for Artificial Intelligence

　More details

Language：Japanese Presentation type：Poster presentation

<p>Outcome prediction using clinical data such as mortality prediction, length-of-stay prediction is applicable to acute change prediction, early treatment, and prediction of treatment effects. However, it is difficult to predict the long-term future status of patients. To improve the performance of the prediction model, we first estimate the short-term future and leverage the estimated value to predict the long-term future status of patients. Such hospitalization progress in the short-term future can be estimated by constructing another estimation model. In this study, we propose the feature expansion using estimated hospitalization progress for the outcome prediction model. We conduct experiments on clinical data of pneumonia cases aggregated in "CITA Clinical Finder", the integrated medical support platform. The result shows our model can predict more accurately than the model without feature expansion.</p>

DOI： 10.11517/pjsai.jsai2022.0_3yin228

CiNii Research
Artificial intelligence-based personalized survival prediction using clinical and radiomics features in patients with advanced non-small cell lung cancer International conference

Koyama Junji, Morise Masahiro, Furukawa Taiki, Oyama Shintaro, Matsuzawa Reiko, Tanaka Ichidai, Wakahara Keiko, Yokota Hideo, Kimura Tomoki, Shiratori Yoshimune, Kondoh Yasuhiro, Hashimoto Naozumi

RESPIROLOGY 2023.2

　More details

Language：English Presentation type：Oral presentation (general)

▼display all

To the head of Presentations.▲

Research Project for Joint Research, Competitive Funding, etc. 8

All Japan大規模レジストリデータを背景とした間質性肺炎の治療プログラム及びデバイスの開発

2022.4 - 2026.3

医療機器等研究成果展開事業

中澤公貴, 五十嵐亮レオナルド, 大山慎太郎

　 More details

Authorship：Principal investigator Grant type：Competitive
間質性肺炎に対する多施設共同前向き観察研究

2020.3 - 2025.12

　 More details

Authorship：Coinvestigator(s) Grant type：Collaborative (industry/university)
特発性肺線維症の運動能力向上と生命予後の改善を目指した、機械学習による最適な呼吸リハビリテーション予測モデルの開発

2023.12 - 2025.3

　 More details

Authorship：Principal investigator Grant type：Competitive
All Japan大規模レジストリデータを背景とした間質性肺炎の遠隔診断と、治療プログラム及びデバイスの事業化検証

2022.8 - 2023.3

大学発新産業創出プログラム（START）大学エコシステム推進型GAPファンドプログラム

古川大記, 大山慎太郎, 五十嵐亮レオナルド

　 More details

Authorship：Principal investigator Grant type：Competitive
医師の業務効率化を支援するアルゴリズムの機械学習

2021.11 - 2023.10

白鳥義宗, 佐藤菊枝, 大山慎太郎, 古川大記

　 More details

Authorship：Coinvestigator(s) Grant type：Collaborative (industry/university)
特発性間質性肺炎の前向きレジストリの構築とインタラクティブMDD診断システムを用いた診断標準化に基づく疫学データの創出―人工知能（AI）診断システムと新規バイオマーカーの開発―

2020.4 - 2022.3

難治性疾患等実用化研究事業

須田隆文, 井上義一, 横田秀夫, 宮崎泰成, 近藤康博, 古川大記, 坂東政司, 小倉高志, 上甲剛, 長谷川好規, 白鳥義宗, 福岡順也, 本間栄

　 More details

Authorship：Coinvestigator(s) Grant type：Competitive
びまん性肺疾患MDD診断のための双方向性Webプラットフォーム構築と人工知能診断の社会実装に関する前向き研究

2019.4 - 2022.3

　 More details

Authorship：Principal investigator Grant type：Competitive
びまん性肺疾患診断の臨床画像クラウド型統合データベースの基盤構築と機械学習による診断・予後予測アルゴリズム構築に関する研究

2019.4 - 2022.3

　 More details

Authorship：Principal investigator Grant type：Competitive

▼display all

To the head of Research Project for Joint Research, Competitive Funding, etc..▲

KAKENHI (Grants-in-Aid for Scientific Research) 7

人工衛星による大気汚染情報を活用した間質性肺炎プレシジョンメディシンの実現

Grant number：23K27610 2024.2 - 2026.3

科学研究費助成事業基盤研究(B)

古川大記

　 More details

Authorship：Principal investigator Grant type：Competitive

Grant amount：\5720000 （ Direct Cost: \4400000 、 Indirect Cost：\1320000 ）
人工衛星による大気汚染情報を活用した間質性肺炎プレシジョンメディシンの実現

Grant number：23H02919 2023.4 - 2026.3

日本学術振興会科学研究費助成事業基盤研究(B) 基盤研究(B)

古川大記, 大山慎太郎, 横田秀夫, 横田秀夫, 大山慎太郎

　 More details

Authorship：Principal investigator Grant type：Competitive

Grant amount：\19370000 （ Direct Cost: \14900000 、 Indirect Cost：\4470000 ）

間質性肺炎は、肺の間質が侵される肺疾患の総称で、多数の診断群と多様な経過をたどる。中でも最も予後不良である特発性肺線維症（IPF）は、正確に診断できる専門医が少ない。同様に予後不良である進行性線維性間質性肺炎(PF-ILD)は、病状が悪化した後にPF-ILD と判断されるため治療導入が遅れてしまうが、診断は困難である。
このため、本研究では前向き・後ろ向きリアルワールド疾患データと大気汚染情報を統合し、データ駆動型研究により疾患の本質を導き出す。
Development of a quantitative evaluation method for medical resource optimization and construction of a regional medical data platform

Grant number：23K09547 2023.4 - 2026.3

Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)

　 More details

Authorship：Coinvestigator(s) Grant type：Competitive

Grant amount：\100000 （ Direct Cost: \100000 ）
Immune-pathological diagnostic artificial intelligence development research for pulmonary fibrosis using fibrotic foci-specific enhanced micro-CT

Grant number：20K21599 2020.7 - 2023.3

Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Challenging Research (Exploratory) Grant-in-Aid for Challenging Research (Exploratory)

Hashimoto Naozumi

　 More details

Authorship：Coinvestigator(s) Grant type：Competitive

Although evaluation by conventional contrast-enhanced CT with X-ray contrast agents provides useful diagnostic information in clinical setting, the aim of this study is to identify lung disease-specific molecules using high-resolution and high-resolution radiographic images derived from contrast-enhanced micro-CT scans with gold nanoparticles as X-ray contrast agents. In this study, we were able to set micro-CT imaging to detect gold nanoparticle-bound lung-specific antibodies in the lung tissue by producing gold nanoparticle-bound lung-specific antibodies and intravenously administering them to living mice. In the future, administration of adjusted dose of gold nanoparticle-bound lung-specific antibody and adequate detection setting of gold nanoparticles bound to lung tissue by micro-CT might give micro-CT immunopathological diagnostic ability.
特発性間質性肺炎の前向きレジストリの構築とインタラクティブMDD診断システムを用いた診断標準化に基づく疫学データの創出―人工知能（AI）診断システムと新規バイオマーカーの開発―

2020.4 - 2022.3

日本医療研究開発機構（AMED）難治性疾患等実用化研究事業

須田隆文, 井上義一, 横田秀夫, 宮崎泰成, 近藤康博, 古川大記, 坂東政司, 小倉高志, 上甲剛, 長谷川好規, 白鳥義宗, 福岡順也, 本間栄

　 More details

Authorship：Coinvestigator(s)
Orality and Narrative Technique in Pain Clinic

Grant number：19KT0027 2019.7 - 2022.3

Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C) Grant-in-Aid for Scientific Research (C)

OYAMA Shintaro

　 More details

Authorship：Coinvestigator(s) Grant type：Competitive

The goal of this study was to develop a medical care learning tool to systematize orality techniques for physicians in the treatment of chronic pain patients. The latter was possible to implement using existing libraries, but the accuracy of facial expressions could not be improved due to the principle of wearing a mask in the examination room. Based on the existing machine learning model, we conducted a dialogue (clinical) test, conducted reinforcement learning with the data, and constructed a model that adapted the Softmax function to the five classes of emotional parameter outputs. The results were reported at a conference.
A Study Development of Machine Learning Algorithm for Diagnosis and Prognosis Prediction of Diffuse Lung Disease

Grant number：19K17633 2019.4 - 2022.3

Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Early-Career Scientists Grant-in-Aid for Early-Career Scientists

Furukawa Taiki

　 More details

Authorship：Principal investigator Grant type：Competitive

Grant amount：\4290000 （ Direct Cost: \3300000 、 Indirect Cost：\990000 ）

In this study, we constructed a large database and developed each artificial intelligence (AI) model for diagnosis and prognosis prediction of interstitial lung diseases.
First, systematic disease data was collected from nationwide specialized hospitals and transformed into a form suitable for AI diagnosis, resulting in a highly accurate diagnostic and prognostic AI. Moreover, we analyzed to make the models generally usable, and reconstructed the AI in order to make the data accessible to non-specialized facilities. A Platform as a Service (PaaS) compatible prototype was built to enable the constructed model to run publicly available applications. With these results, we achieved our research goal of " constructing a database of interstitial lung diseases and developing highly accurate AI diagnostic and prognostic predictions.

▼display all

To the head of KAKENHI (Grants-in-Aid for Scientific Research).▲

Industrial property rights 9

情報処理装置、情報処理方法、および、コンピュータプログラム

寺町涼, 古川大記, 烏山昌幸, 横田秀夫

　More details

Applicant：国立大学法人東海国立大学機構

Application no：特願2022-175512 Date applied：2022.11
Identifying device, learning device, method, and storage medium

Taiki FURUKAWA, Hideo Yokota, Shintaro OYAMA, Yoshinori Hasegawa, Yoshimune SHIRATORI

　More details

Application no：特願US20200372650 Date applied：2020.5

Date announced：2020.11

Patent/Registration no：特許US11,361,443 B2 Date registered：2022.6
判別装置、学習装置、方法、プログラム、学習済みモデルおよび記憶媒体

古川大記, 横田秀夫, 大山慎太郎, 長谷川好規, 白鳥義宗

　More details

Applicant：国立研究開発法人理化学研究所

Application no：特願2019-094757 Date applied：2019.5

Announcement no：特開2020-188872 Date announced：2020.11

Patent/Registration no：特許第7334900号 Date registered：2023.8

J-GLOBAL
文書作成支援装置、文書作成支援方法、及び文書作成支援プログラム

古川大記, 大山慎太郎, 他

　More details

Applicant：国立大学法人東海国立大学機構

Application no：特願2023-166471 Date applied：2023.7
Identifying device, learning device, method, and storage medium

　More details

Applicant：国立研究開発法人理化学研究所

Application no：特願2023-109008 Date applied：2023.7
Identifying device, learning device, method, and storage medium

　More details

Applicant：国立研究開発法人理化学研究所

Application no：特願2023-109002 Date applied：2023.7
情報処理装置

古川大記

　More details

Applicant：国立大学法人東海国立大学機構名古屋大学

Application no：特願2022-1388807 Date applied：2022.8
情報処理装置

古川大記

　More details

Applicant：国立大学法人東海国立大学機構名古屋大学

Application no：特願2022-1388808 Date applied：2022.8
情報処理装置、情報処理方法、および、コンピュータプログラム

神山潤二, 古川大記, 森瀬昌宏, 横田秀夫

　More details

Application no：特願2022-043291 Date applied：2022.3

▼display all

To the head of Industrial property rights.▲

Teaching Experience (On-campus) 4

生命医療データ学

2023
医療情報学

2023
生命医療データ学

2022
医療情報学

2022

To the head of Teaching Experience (On-campus).▲

Teaching Experience (Off-campus) 1

医療情報学

2021.4

To the head of Teaching Experience (Off-campus).▲

Media Coverage 3

間質性肺炎高齢化で増息切れ、せき見逃さずに予後悪く原因別で多様な種類 Newspaper, magazine

中日新聞、東京新聞、北陸中日新聞 2024.4

　More details

Author：Other
難病・特発性肺線維症名大と理研が高精度診断ＡＩ開発 Newspaper, magazine

中日新聞、東京新聞、北陸中日新聞 2023.10

　More details

Author：Other
難病・特発性肺線維症　名大と理研が高精度診断ＡＩ開発 Newspaper, magazine

中日新聞 https://www.chunichi.co.jp/article/794814 2023.10

　More details

Author：Other

To the head of Media Coverage.▲